Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine

In this work systematization (classification) of biochemical and physiological processes that cause disorders in the human body during the development of diabetes mellitus is carried out. The development of the disease is considered as the interaction and mutual reinforcement of two groups of parall...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Semen V. Nesterov, Lev S. Yaguzhinsky, Gennady I. Podoprigora, Yaroslav R. Nartsissov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2018
Materias:
Acceso en línea:https://doaj.org/article/0520b12109b0433089072c438fbb3006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0520b12109b0433089072c438fbb3006
record_format dspace
spelling oai:doaj.org-article:0520b12109b0433089072c438fbb30062021-11-14T09:00:21ZAutocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine2072-03512072-037810.14341/DM9529https://doaj.org/article/0520b12109b0433089072c438fbb30062018-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9529https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378In this work systematization (classification) of biochemical and physiological processes that cause disorders in the human body during the development of diabetes mellitus is carried out. The development of the disease is considered as the interaction and mutual reinforcement of two groups of parallel processes. The first group has a molecular nature and it is associated with impairment of ROS-regulation system which includes NADPH oxidases, RAGE receptors, mitochondria, cellular peroxireductase system and the immune system. The second group has a pathophysiological nature and it is associated with impairment of microcirculation and liver metabolism. The analysis of diabetes biochemistry based on different published references yields a creation of a block diagram evaluating the disease development over time. Two types of autocatalytic processes were identified: autocatalysis in the cascade of biochemical reactions and "cross-section" catalysis, in which biochemical and pathophysiological processes reinforce each other. The developed model has shown the possibility of using pharmacologically active natural metabolite glycine as a medicine inhibiting the development of diabetes. Despite the fact that glycine is a substitute amino acid the drop in the glycine blood concentration occurs even in the early stages of diabetes development and can aggravate the disease. It is shown that glycine is a potential blocker of key autocatalytic cycles, including biochemical and pathophysiological processes. The analysis of the glycine action based on the developed model is in complete agreement with the results of clinical trials in which glycine has improved blood biochemistry of diabetic patients and thereby it prevents the development of diabetic complications.Semen V. NesterovLev S. YaguzhinskyGennady I. PodoprigoraYaroslav R. NartsissovEndocrinology Research Centrearticlediabetes mellitusglycinemicrocirculationadvanced glycosylation end productsinflammationreactive oxygen speciesNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 21, Iss 4, Pp 283-292 (2018)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus
glycine
microcirculation
advanced glycosylation end products
inflammation
reactive oxygen species
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus
glycine
microcirculation
advanced glycosylation end products
inflammation
reactive oxygen species
Nutritional diseases. Deficiency diseases
RC620-627
Semen V. Nesterov
Lev S. Yaguzhinsky
Gennady I. Podoprigora
Yaroslav R. Nartsissov
Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
description In this work systematization (classification) of biochemical and physiological processes that cause disorders in the human body during the development of diabetes mellitus is carried out. The development of the disease is considered as the interaction and mutual reinforcement of two groups of parallel processes. The first group has a molecular nature and it is associated with impairment of ROS-regulation system which includes NADPH oxidases, RAGE receptors, mitochondria, cellular peroxireductase system and the immune system. The second group has a pathophysiological nature and it is associated with impairment of microcirculation and liver metabolism. The analysis of diabetes biochemistry based on different published references yields a creation of a block diagram evaluating the disease development over time. Two types of autocatalytic processes were identified: autocatalysis in the cascade of biochemical reactions and "cross-section" catalysis, in which biochemical and pathophysiological processes reinforce each other. The developed model has shown the possibility of using pharmacologically active natural metabolite glycine as a medicine inhibiting the development of diabetes. Despite the fact that glycine is a substitute amino acid the drop in the glycine blood concentration occurs even in the early stages of diabetes development and can aggravate the disease. It is shown that glycine is a potential blocker of key autocatalytic cycles, including biochemical and pathophysiological processes. The analysis of the glycine action based on the developed model is in complete agreement with the results of clinical trials in which glycine has improved blood biochemistry of diabetic patients and thereby it prevents the development of diabetic complications.
format article
author Semen V. Nesterov
Lev S. Yaguzhinsky
Gennady I. Podoprigora
Yaroslav R. Nartsissov
author_facet Semen V. Nesterov
Lev S. Yaguzhinsky
Gennady I. Podoprigora
Yaroslav R. Nartsissov
author_sort Semen V. Nesterov
title Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
title_short Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
title_full Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
title_fullStr Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
title_full_unstemmed Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
title_sort autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
publisher Endocrinology Research Centre
publishDate 2018
url https://doaj.org/article/0520b12109b0433089072c438fbb3006
work_keys_str_mv AT semenvnesterov autocatalyticcycleinthepathogenesisofdiabetesmellitusbiochemicalandpathophysiologicalaspectsofmetabolictherapywithnaturalaminoacidsontheexampleofglycine
AT levsyaguzhinsky autocatalyticcycleinthepathogenesisofdiabetesmellitusbiochemicalandpathophysiologicalaspectsofmetabolictherapywithnaturalaminoacidsontheexampleofglycine
AT gennadyipodoprigora autocatalyticcycleinthepathogenesisofdiabetesmellitusbiochemicalandpathophysiologicalaspectsofmetabolictherapywithnaturalaminoacidsontheexampleofglycine
AT yaroslavrnartsissov autocatalyticcycleinthepathogenesisofdiabetesmellitusbiochemicalandpathophysiologicalaspectsofmetabolictherapywithnaturalaminoacidsontheexampleofglycine
_version_ 1718429506527559680